FSD Pharma Inc. (0K9.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 06:49PM CEST
| Previous close | 0.3835 |
| Open | 0.3320 |
| Bid | 0.3415 x N/A |
| Ask | 0.3515 x N/A |
| Day's range | 0.3295 - 0.3550 |
| 52-week range | 0.3295 - 1.4950 |
| Volume | |
| Avg. volume | 340 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 10 May 2024 - 14 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireGBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss Case
The Court concludes that Plaintiff has sufficiently demonstrated that its trade secrets derived economic value from not being readily ascertainable by othersWESTON, Fla., Jan. 11, 2024 (GLOBE NEWSWIRE) -- GBB Drink Lab. Inc (“GBB” or the “Company”), a maker of the world’s first rapid blood alcohol detoxification beverage, is pleased to announce that a federal court has refused to dismiss the Company’s ongoing lawsuit against FSD Pharma. FSD Pharma (NASDAQ: HUGE), a clinical-stage biotech company
© 2024 Yahoo. All rights reserved.